Murai, K.; Vasigh, A.; Alexy, T.; Tóth, K.; Czopf, L.
The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence. Biomedicines 2024, 12, 1669.
https://doi.org/10.3390/biomedicines12081669
AMA Style
Murai K, Vasigh A, Alexy T, Tóth K, Czopf L.
The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence. Biomedicines. 2024; 12(8):1669.
https://doi.org/10.3390/biomedicines12081669
Chicago/Turabian Style
Murai, Kyosuke, Amir Vasigh, Tamás Alexy, Kálmán Tóth, and László Czopf.
2024. "The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence" Biomedicines 12, no. 8: 1669.
https://doi.org/10.3390/biomedicines12081669
APA Style
Murai, K., Vasigh, A., Alexy, T., Tóth, K., & Czopf, L.
(2024). The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence. Biomedicines, 12(8), 1669.
https://doi.org/10.3390/biomedicines12081669